Updated Labeling for Vaping Products

Overseen By Grace Kong, PhD

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: Yale University

Disqualifiers: Children under 14 years

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

What You Need to Know Before You Apply

What is the purpose of this trial?

Current labels for the nicotine in e-cigarette/vaping products do not sufficiently convey information to the public. The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and nicotine flux (reflecting nicotine emissions). Investigators will survey youth (ages 14-20) and adults (ages 21+ \[21 is the legal age to purchase tobacco products in the U.S.\]) to evaluate the utility of several new labels investigators have developed.

Are You a Good Fit for This Trial?

Inclusion Criteria

* Reports no history of tobacco product use (25% of the youth and adult samples, respectively) or past-month use of e-cigarettes (but not cigarettes; 25%), cigarettes (but not e-cigarettes; 25%), or both e-cigarettes and cigarettes (25%).

I am 14 years old or older.

I am either under 21 or 21 years old and above.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Survey

Participants are surveyed to evaluate the utility of new nicotine labels

20 minutes

1 visit (virtual)

Follow-up

Participants are monitored for understanding and perception of nicotine strength and addictiveness

1 week

What Are the Treatments Tested in This Trial?

Interventions

• Updated Labeling

How Is the Trial Designed?

Group I: Flux Label 3 Experimental Treatment 1 Intervention

Participants may be randomized to view Version 3 of the flux label

Group II: Flux Label 2 Experimental Treatment 1 Intervention

Participants may be randomized to view Version 2 of the flux label

Group III: Flux Label 1 Experimental Treatment 1 Intervention

Participants may be randomized to view Version 1 of the flux label

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+